Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tezampanel in Acute Migraine
NCT00567086Phase 2Completed
- Sponsor
- TorreyPines Therapeutics
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tezampanel in migraine (4 arms), sponsored by TorreyPines Therapeutics. Primary endpoint: Headache response at 2 hours. Started Oct 2006; status: completed.
02
Drugs
tezampanel
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00567086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567086.